Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Raboud

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
The Journal of Infectious Diseases|September 9, 1999
Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitationJ M Raboud, S Rae, R S Hogg, et al.
AIDS (London, England)|February 1, 1993
Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT TrialJ S Montaner, J Singer, M T Schechter, et al.
Annals of Epidemiology|May 1, 1993
Ongoing high-risk sexual behaviors in relation recreational drug use in sexual encounters. Analysis of 5 years of data from the Toronto Sexual Contact StudyL M Calzavara, R A Coates, J M Raboud, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 10, 1999
Violence in the emergency department: a survey of health care workersC M Fernandes, F Bouthillette, J M Raboud, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assaysJ M Raboud, E Seminari, S L Rae, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|December 9, 2010
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practiceTony Antoniou, J M Raboud, C Diong, et al.
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.
AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.
Antiviral Therapy|May 1, 2001
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individualsJ M Raboud, J S Montaner, S Rae, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
International Journal of STD & AIDS|April 20, 2000
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study GroupJ Singer, A Thorne, S Khorasheh, et al.
The Journal of Infectious Diseases|September 9, 1999
Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitationJ M Raboud, S Rae, R S Hogg, et al.
AIDS (London, England)|February 1, 1993
Clinical correlates of in vitro HIV-1 resistance ot zidovudine. Results of the Multicentre Canadian AZT TrialJ S Montaner, J Singer, M T Schechter, et al.
Annals of Epidemiology|May 1, 1993
Ongoing high-risk sexual behaviors in relation recreational drug use in sexual encounters. Analysis of 5 years of data from the Toronto Sexual Contact StudyL M Calzavara, R A Coates, J M Raboud, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 10, 1999
Violence in the emergency department: a survey of health care workersC M Fernandes, F Bouthillette, J M Raboud, et al.
Journal of Clinical Microbiology|October 17, 1998
Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assaysJ M Raboud, E Seminari, S L Rae, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|December 9, 2010
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practiceTony Antoniou, J M Raboud, C Diong, et al.
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.
AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.
Antiviral Therapy|May 1, 2001
Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individualsJ M Raboud, J S Montaner, S Rae, et al.
Pageof 4